Latest Compliance News

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.

Latrobe Magnesium has achieved continuous production of high-grade Magnesium Oxide from brown coal ash and secured a US$2 million prepayment from its US offtake partner, setting the stage for magnesium metal production in the second half of 2026.

Rhythm Biosciences marked a pivotal shift from development to commercial diagnostics in Q3 FY26, recording its first ColoSTAT® clinical sale and initiating NHS England evaluation while expanding geneType™ partnerships across Asia and Australia.

Sierra Nevada Gold (ASX: SNX) advances its As Safra copper-gold project in Saudi Arabia by establishing a local subsidiary and preparing for imminent drilling after securing exploration licences.

Ioneer Ltd has raised US$50 million to push forward its fully permitted Rhyolite Ridge lithium-boron project in Nevada, buoyed by a federal court ruling upholding project approvals and ongoing strategic partner discussions.

D3 Energy has significantly expanded its South African helium footprint with new Exploration Rights and a Technical Cooperation Permit, while completing a well-supported A$6.12 million placement to fund upcoming drilling and development activities.

Maronan Metals secured Mineral Development Licence 2028, unlocking underground exploration, while metallurgical tests showed gold recoveries up to 88% and copper recoveries exceeding 96%. The company expanded its drilling program and bolstered leadership amid steady progress toward mine development.

Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.

Alara Resources maintained steady copper-gold production at its Al Wash-hi Majaza Mine despite regional geopolitical shipping disruptions, while advancing exploration and managing ongoing legal proceedings in Oman.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Jade Gas Holdings has completed its appraisal program at the Tavan Tolgoi coal bed methane project, preparing to lodge its maiden gas reserve booking and advance development plans backed by fresh capital.